Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections

Journal of the American Academy of Dermatology
Shivani B Kaushik, Mark G Lebwohl

Abstract

Despite the availability of several new systemic agents for psoriasis treatment, choosing the right therapy in certain patient populations can be challenging. There are few up-to-date reviews on systemic drugs for moderate to severe psoriasis in pregnant and pediatric patients and in patients with concomitant chronic infections, such as hepatitis, HIV, and latent tuberculosis. These groups are usually excluded from clinical trials, and much of the available evidence is based on anecdotal case reports and case series. As a chronic disease, psoriasis requires long-term treatment, and there are concerns of adverse maternal-fetal outcomes, long-term side effects in children, and the reactivation of latent infections with the use of systemic agents in these patients. The second article in this continuing medical education series provides insights for choosing appropriate systemic agents for treating moderate to severe psoriasis in pregnant and pediatric patients and in the setting of chronic infections, such as hepatitis, HIV, and latent tuberculosis.

Citations

Nov 16, 2018·The Journal of Dermatological Treatment·Kerasia-Maria Plachouri, Sophia Georgiou
Dec 24, 2018·Dermatology and Therapy·Bruce E StroberAlexa B Kimball
Feb 27, 2019·American Journal of Clinical Dermatology·Khatiya ChelidzeEsther Ellen Freeman
Jan 12, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·F MaccariUNKNOWN GEM RESOPSO and the AJDerm
Mar 5, 2019·Expert Opinion on Biological Therapy·Kristen M Beck, John Koo
May 14, 2019·Current Medical Research and Opinion·Sara HigaAasthaa Bansal
Jul 5, 2019·Expert Opinion on Pharmacotherapy·S D'AdamioM Galluzzo
Mar 29, 2019·American Journal of Clinical Dermatology·Igor SnastLev Pavlovsky
Oct 7, 2019·The Journal of Dermatology·Hiroshi Saruwatari
Oct 19, 2019·Expert Opinion on Drug Metabolism & Toxicology·Anna CampanatiAnnamaria Offidani
Jan 10, 2020·Expert Review of Clinical Immunology·Maria EspositoMaria Concetta Fargnoli
Aug 28, 2019·American Journal of Clinical Dermatology·Nicola E NatsisAlice B Gottlieb
Sep 4, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·M G LebwohlC Paul
Oct 20, 2019·Dermatologic Therapy·Beniamin Oskar GrabarekAnna Michalska-Bańkowska
Sep 4, 2019·Expert Opinion on Drug Safety·S D'AdamioM Galluzzo
Feb 6, 2020·Dermatologic Therapy·Samia IbrahimAhmed Abdellatif
Mar 4, 2020·International Journal of Molecular Sciences·Masahiro Kamata, Yayoi Tada
Mar 5, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S MüllerD Wilsmann-Theis
Feb 23, 2020·Expert Opinion on Biological Therapy·Monica Rosales SantillanAlexa B Kimball
Feb 6, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·E FowlerJ J Wu
Mar 10, 2020·Expert Review of Clinical Immunology·Francesco CasoLuisa Costa
Jan 27, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·B ElewskiG Yosipovitch
Apr 7, 2020·Expert Opinion on Drug Safety·A ZangrilliL Bianchi
Mar 3, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·Claire PascalAudrey Nosbaum
Apr 7, 2020·The Journal of Dermatological Treatment·Federico BardazziAmbra Di Altobrando
May 29, 2020·Expert Opinion on Biological Therapy·Paolo Gisondi, Giampiero Girolomoni
Jul 9, 2020·Journal of Comparative Effectiveness Research·Jashin J WuJeffrey R Curtis
Jul 23, 2020·Scandinavian Journal of Immunology·Lisa Lynn Ten BergenSilke Appel
Sep 14, 2019·Children·Abigail ClineSteven R Feldman
Jul 28, 2019·International Journal of Dermatology·Adriana N PassosMaria de F S P de Oliveira
Oct 3, 2019·Expert Review of Clinical Immunology·Lajos KeményZoltan Novak
Jan 10, 2020·Dermatologic Therapy·Ersoy AcerZeynep N Saracoğlu
May 18, 2020·Current Obesity Reports·Kyriaki ParoutoglouMaria Dalamaga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Canadian Journal of Plastic Surgery = Journal Canadien De Chirurgie Plastique
Daniel McKeeJoel Fish
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Yujiro Tanaka
The American Journal of Gastroenterology
Alfredo PapaAntonio Gasbarrini
Actas dermo-sifiliográficas
V RuizL Puig
© 2022 Meta ULC. All rights reserved